Deka Research & Dev Corp is categorized under Commercial Medical Research in Manchester, NH .
Deka Research & Dev Corp was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 5417115 by the NAICS.
If you are seeking more information, feel free to contact Dean Kamen, President at the company’s single location by writing to 340 Commercial St # 401, Manchester, New Hampshire NH 03101 or by phoning (603) 669-5139. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Deka Research & Dev Corp |
| Contact Person: | Dean Kamen, President |
| Address: | 340 Commercial St # 401, Manchester, New Hampshire 03101 |
| Phone Number: | (603) 669-5139 |
| Website Address: | dekaresearch.com |
| Annual Revenue (USD): | Unknown |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Medical Research |
| SIC Code: | 8731 |
| NAICS Code: | 5417115 |
| Share This Business: |
Deka Research & Dev Corp was started in 0 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 5417115. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Dean Kamen, President for inquiries that concern Deka Research & Dev Corp by calling the company number (603) 669-5139, as your correspondence is most welcome. Additionally, the physical location of the single location of Deka Research & Dev Corp can be found at the coordinates 42.9915,-71.46782 as well as the street address 340 Commercial St # 401 in Manchester, New Hampshire 03101.
For its online presence, you may visit Deka Research & Dev Corp’s website at dekaresearch.com and engage with its social media outlets through on Twitter and on Facebook.